Login or sign up
For business
Average ratingGreat
4.4/ 5

Based on 9 reviews

556%
433%
311%
20%
10%
Ask AI

Ask AI about Encore Vision

Generated with AI from 9 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Encore Vision

Encore Vision is developing a technology for the treatment of presbyopia. The company has been well-financed and mentored by ophthalmologists and optometrists during its incubation phase. Encore Vision has achieved significant progress in developing extensive Intellectual Property protection.

Encore Vision’s technology is covered by a robust and growing patent portfolio which includes one issued broad-based US patent, a notice of allowance on a second U.S. patent, and more than 40 Pending the US and foreign patent applications and provisional filings, including the composition of matter applications for its proprietary formulations. The company has completed in-vivo proof of concept in an animal model for presbyopia and has begun development activities leading to clinical studies in man.

It was established in 2000 and is headquartered in Fort Worth, Texas.